30 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
to successfully develop, gain regulatory approval of and commercialize products. Intense competition for attracting key skill-sets may limit our ability … the Services in a good and workman-like manner, to the best of the Consultant’s ability and using the Consultant’s best efforts, skill, and judgement
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
to successfully develop, gain regulatory approval of and commercialize products. Intense competition for attracting key skill-sets may limit our ability … the Services in a good and workman-like manner, to the best of the Consultant’s ability and using the Consultant’s best efforts, skill, and judgement
POS AM
EX-10.26
keyn5cfc2lxxez0
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.2
847mnmwjtw240z
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.3
vm8a450q4aszpaenr0kc
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
aktrsi
19 Dec 22
XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study
8:12am
424B4
rhi 3yuir64s6
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
64o6w4i0qom
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
6omgf
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
47ufhj155yr
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
rwktnf 17evei8n45
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
gp12j4gg2z9jw5
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
79c6zm
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.27
te4jwhv5
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.21
41ql6mphj79qrykr
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.20
xnbbg8vl9 8p34m
3 May 22
Annual report (foreign)
5:29pm